ID   QHJI01s04
AC   CVCL_C1E1
SY   QHJI 01s04
DR   Wikidata; Q114312751
RX   PubMed=31497180;
RX   PubMed=32668747;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/QHJI01s01_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; C*12:01; DPB1*:09:01; DQB1*:06:01; DRB1*15:02 (PubMed=32668747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1DX ! Ff-I01s01
OI   CVCL_C1DY ! Ff-I01s04
OI   CVCL_C1DZ ! Ff-I14s03
OI   CVCL_C1DM ! Ff-I14s04
OI   CVCL_C1E0 ! QHJI01s01
OI   CVCL_C1E2 ! QHJI14s03
OI   CVCL_C1DN ! QHJI14s04
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=31497180; DOI=10.1186/s41232-019-0106-0; PMCID=PMC6717959;
RA   Umekage M., Sato Y., Takasu N.;
RT   "Overview: an iPS cell stock at CiRA.";
RL   Inflamm. Regen. 39:17.1-17.5(2019).
//
RX   PubMed=32668747; DOI=10.3390/jcm9072217; PMCID=PMC7408794;
RA   Sugita S., Mandai M., Hirami Y., Takagi S., Maeda T., Fujihara M.,
RA   Matsuzaki M., Yamamoto M., Iseki K., Hayashi N., Hono A., Fujino S.,
RA   Koide N., Sakai N., Shibata Y., Terada M., Nishida M., Dohi H.,
RA   Nomura M., Amano N., Sakaguchi H., Hara C., Maruyama K., Daimon T.,
RA   Igeta M., Oda T., Shirono U., Tozaki M., Totani K., Sugiyama S.,
RA   Nishida K., Kurimoto Y., Takahashi M.;
RT   "HLA-matched allogeneic iPS cells-derived RPE transplantation for
RT   macular degeneration.";
RL   J. Clin. Med. 9:2217.1-2217.18(2020).
//
RX   PubMed=36395757; DOI=10.1016/j.medj.2022.10.003;
RA   Yoshida S., Kato T.M., Sato Y., Umekage M., Ichisaka T., Tsukahara M.,
RA   Takasu N., Yamanaka S.;
RT   "A clinical-grade HLA haplobank of human induced pluripotent stem
RT   cells matching approximately 40% of the Japanese population.";
RL   Med 4:51-66.e10(2023).
//